FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:1667-1669 April 16, 2009 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Meador, K. J. PubMed Citation

Approximately 25,000 children are born in the United States each year to mothers with epilepsy.¹ Most of these women need to continue taking medication during pregnancy, since uncontrolled seizures may be harmful to the women as well as to the fetuses.² The challenge to physicians is to prescribe a treatment that is effective in controlling seizures but has minimal associated risks.

More than 40 years have passed since the first report on increased rates of birth defects in the offspring of women with epilepsy.³ Subsequent research has clarified that this is related to the antiepileptic drugs rather than the underlying . . . [Full Text of this Article]

Source Information

From the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm.

This article has been cited by other articles:

• (2009). In Utero Antiepileptic Drug Exposure and Childhood IQ. JWatch Neurology 2009: 1-1 [Full Text]